Benzoquinolizinium salt derivatives as anticancer agents

Details for Australian Patent Application No. 2010275640 (hide)

Owner Naxopharma S.R.L.

Inventors Lombardi, Paolo; Buzzetti, Franco; Arcamone, Andrea Guido

Agent Watermark

Pub. Number AU-A-2010275640

PCT Pub. Number WO2011/009714

Priority 12/458,657 20.07.09 US

Filing date 6 July 2010

Wipo publication date 27 January 2011

International Classifications

C07D 455/03 (2006.01) Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/009714 Priority application(s): WO2011/009714

28 June 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Naxopharma S.R.L., Application No. 2010275640, under INID (71) correct the applicant name to read Naxospharma S.R.L. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A the date of this Journal. 2005305130 Johnson & Johnson Vision Care, Inc. 2006268323 Quantum Paper, Inc. 2008204344 Debiopharm SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010275672-Improved host cell for the production of a compound of interest

2010275595-Elevator car